Anton Rx Report

Register Now to Get the Anton Rx Report in your Inbox


FDA Approves 34th Biosimilar

Lo and behold…… the FDA approved yet another biosimilar to Filgrastim.This follow-on product joins two previously approved biosimilars to Neupogen and was christened Releuko (filgrastim-ayow)

Read More »

This website uses cookies to ensure you get the best experience on our website.